Upcoming Medical Conferences in Chicago

Adult-Gerontology Acute Care Nurse Practitioners (AGACNP) Course is organized by Barkley & Associates, Inc. and will be held from May 25 - 26, 2019 at Palmer House a Hilton Hotel, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 16.25 Contact Hours of Continuing Education . Conference Topics: • Clinical Assessment • Common Problems in Acute Care • Diagnosis and Clinical Management for Adults • Extensive Review of System-Specific Health Problems • Health Care Delivery and Health Care Systems • Health Promotion and Disease Prevention • Nurse Practitioner/Patient Relationship • Pharmacologic management • Professional Role Additional details will be posted as soon as they are available.

Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC (May 2019) is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, oncology nurses, pharmacists, and other healthcare providers who care for patients with non-small-cell lung cancer. Accreditation: Physician Continuing Medical Education: The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Continuing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacist Continuing Education: Credit Designation: Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. Goal Statement: The goal of this activity is to improve participants’ knowledge of and competence in applying EGFR inhibitors in the treatment of patients with EGFR-mutated non-small-cell lung cancer. Learning Objectives: • Apply expert recommendations for frontline therapy for advanced EGFR-mutated NSCLC focusing on safety, efficacy, and the individualization of therapy based on tumor-specific and patient-specific factors • Compare the efficacy and safety of first-generation EGFR TKIs with later-generation EGFR TKIs • Examine current recommendations for molecular testing and the roles for liquid biopsies in guiding the use of EGFR TKI therapy • Plan optimal sequencing of EGFR TKIs after considering the available evidence and expert recommendations • Evaluate current and evolving treatment approaches to address acquired resistance and progression in advanced EGFR-mutated NSCLC

An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits™. Target Audience: This program is intended for oncologists and other allied healthcare professionals caring for patients with metastatic breast cancer receiving targeted therapy. Goal Statement: The goal of this activity is to improve the knowledge, confidence, and competence of oncology specialists and other clinicians caring for their patients with MBC receiving CDK4/6 inhibitors, mTOR inhibitors, PI3K inhibitors, and promising investigational agents. Learning Objectives: • Evaluate current guidelines and current/emerging clinical trial data on everolimus, palbociclib, palbociclib, and abemaciclib (in addition to others under clinical investigation) to aid in the refinement of current treatment algorithms for patients with de novo or recurrent HR-positive/HER2-negative MBC • Describe current therapeutic strategies and ongoing clinical trials of targeted therapy–based combinations for both early-stage and HR-positive, HER2-negative MBC • Identify ongoing trials investigating novel treatment options after disease progression on endocrine and/or CDK4/6 inhibitor-based therapy to aid in clinical trial participation  Additional details will be posted as soon as they are available.

B-Cell Malignancies - Expert Guidance on BTK Inhibitors for Today’s Clinic is organized by Clinical Care Options (CCO), LLC and will be held on Jun 01, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits™. Target Audience  This program is intended for hematologists, hematologist-oncologists, and other clinicians involved in the management of patients with MCL, CLL, and other B-cell malignancies. Goal Statement The goal of this activity is to improve participants’ competence in using BTK inhibitors to improve treatment outcomes for patients with B-cell malignancies. Learning Objectives  • Evaluate differences among agents targeting BTK in terms of molecular characteristics, preclinical data, approved indications, dosing, safety profile, and efficacy • Consider existing and emerging clinical research data evaluating currently available and emerging BTK inhibitors (and BTK-based combinations) in the formulation of therapeutic recommendations for patients with MCL, CLL, and other B-cell malignancies • Recognize and manage adverse events and toxicities associated with BTK inhibitor therapy to support quality of life and continuation of treatment • Explain to patients the importance of and provide strategies for optimal adherence to prescribed BTK inhibitors • Assess ongoing clinical trials evaluating currently available and emerging BTK inhibitors (and BTK-based combinations) to aid clinical trial enrollment and predict new options in the clinic  Additional details will be posted as soon as they are available.

PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing is organized by Clinical Care Options (CCO), LLC and will be held on Jun 01, 2019 at Radisson Blu Aqua Hotel, Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, nurses, pharmacists, and other healthcare providers who care for patients with metastatic breast cancer. Accreditation: Physicians: NCCN designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: NCCN designates this educational activity for a maximum of 2.0 contact hours. Pharmacists: NCCN designates this knowledge-based continuing education activity for 2.0 contact hours (0.2 CEUs) of continuing education credit. Goal Statement: The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer. Learning Objectives: • Describe the mechanism of action of the different PARP inhibitors and the rationale for PARP inhibition in treating metastatic breast cancer • Identify patients based on molecular changes and previous therapy that are most likely to benefit from treatments with PARP inhibitors • Integrate single-agent PARP inhibitors into the treatment of appropriately selected patients with metastatic breast cancer •Refer eligible patients with metastatic breast cancer to clinical trials of single-agent PARP inhibitors and combinations of PARP inhibitors with other anticancer therapies  Additional details will be posted as soon as they are available.

Ophthalmology Oral Lectures Course is organized by The Osler Institute and will be held from Jun 02 - 06, 2019 at Holiday Inn & Suites Chicago North Shore (Skokie), Chicago, Illinois, United States of America. This Course has been approved for a maximum of 50 AMA PRA Category 1 Credit(s)™. Optional extra day of Mock Orals (June 7): Designation: The Osler Institute designates this optional Live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Participants receive one complimentary 30 min public Mock Oral session with registration for the extra day. Participants and faculty meet face-to-face in a half-hour simulation of the oral board process followed by faculty critique. When not participating in your own public Mock Oral exam you will have the opportunity to view the public sessions of other participants. Learn by doing and observing others. Enter Mock Oral topic preference in the indicated box when registering. Course Description: This five-day course includes presentations that review the entire field of Ophthalmology using both a didactic lecture approach as well as case-based reviews. Emphasis is on evidence-based medicine and board-relevant standard of care. As a result, the course provides the perfect review for the ABO oral certification exam as well as a good overall review for the DOCK exam or for physicians in practice. Many of our previous participants found the course provided them with improved diagnostic and evaluation skills and helped them recognize specific areas of weakness for self-study. The course includes lectures with a complimentary searchable e-syllabus (PDFs of all PowerPoint presentations) as well as mock oral exams to observe without charge (June 5 and 6). Additional details will be posted as soon as they are available.

Collaborative Strategies to Ensure Optimal Application of the Latest Treatment Approaches in HCC is organized by Clinical Care Options (CCO), LLC and will be held on Jun 02, 2019 at Radisson Blu Aqua Hotel, Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare providers who care for patients with HCC. Accreditation: NCCN designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: NCCN designates this educational activity for a maximum of 2.0 contact hours. Pharmacists: NCCN designates this knowledge-based continuing education activity for 2.0 contact hours (0.2 CEUs) of continuing education credit. Goal Statement: The goal of this activity is to improve participants’ competence in applying the latest treatment approaches and interdisciplinary collaborative strategies towards optimal care of patients with HCC. Learning Objectives: • Explore first-line treatment options for individual patients with advanced HCC, considering the available clinical evidence, known agent toxicity/ tolerability profiles, expert recommendations, and patient preferences • Apply clinical evidence and expert recommendations to select optimal treatment for patients with HCC        that has progressed on or after 1 or multiple lines of therapy • Plan therapeutic strategies that optimize the sequence of therapies to provide the best outcome to patients      with HCC • Counsel patients to help them understand their treatment options and to be proactive, knowledgeable            participants in their care • Employ effective collaborative strategies to ensure the best possible application of the latest HCC                  treatment approaches • Become familiar with the design of ongoing clinical trials for novel HCC treatment strategies, and counsel    appropriate patients about availability and participation

Thoracic Surgery Mock Oral Review Course is organized by The Osler Institute and will be held from Jun 04 - 06, 2019 at Holiday Inn Chicago Oakbrook, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 30 AMA PRA Category 1 Credit(s)™. Course Description : Hone your critical reasoning and evaluation skills in an intensive 3-day case review course designed to help you zero in on what is most clinically relevant for diagnosis, surgical approach, and case management in all essential areas of Thoracic Surgery. The course covers standard of care relevant cases utilizing a half-hour public mock oral exam with feedback format. The course begins with a lecture on the critical reasoning and communication skills important to passing the Oral Certification exam and that will be emphasized during the mock oral exams to follow. Participants and faculty review one-on-one in a 25-minute simulation of the oral board process followed by faculty critique and audience response; 2-4 cases are reviewed in each 30-minute session for a total of 40-80 case reviews per day. Course fees include participating in one public mock oral exam and observing others being examined. Learn from doing and from observing. You may purchase as many additional public or private mock oral exams as you like; however, availability and topics may be limited within two weeks of the course. Please contact the Osler office prior to that time to ensure availability. Topics: • bronchogenic cysts • aortic aneurysms • chest wall tumors • pancoast tumors • septal ruptures • thoracic trauma • esophageal surgeries • cardiac transplants • mitral valve disease • lung abscess • parapneumonic effusion • tracheal strictures and tumors • cardiac tumors • lung cancer • emphysema and bullous disease • pneumothorax • congenital heart disease • mediastinal masses • ventricular aneurysms • mesothelioma • thoracic duct tumors • chylothorax • aortic dissection • CABG Additional details will be posted as soon as they are available.

17th Annual American Academy of Clinical Neuropsychology (AACN) Conference is organized by American Academy of Clinical Neuropsychology (AACN) and will be held from Jun 05 - 08, 2019 at Chicago Marriott Downtown Magnificent Mile, Chicago, Illinois, United States of America. This Conference has been approved for a maximum of 19 CEs. Description: Each year clinical neuropsychologists from around the world gather for the AACN’s Annual Conference. This event brings together psychologists with similar interests for educational workshops and networking events. No matter what your role in the field, the AACN Conference offers master workshops and advanced training for all members and non-members alike. The conference offers high-quality workshop content, a concentrated scientific program, and multiple opportunities for vendors to interact closely with conference attendees. Our attendees are comprised of a broad range of students, newly boarded and seasoned scientist-practitioners at the highest level of professional practice - committed to remaining current with respect to the research literature, new practice tools, and the latest updates to test instruments, scholarly books and texts, and technological advances with clinical application. Indeed, these clinicians represent a uniquely concentrated selection of highly qualified present and future authors, test developers, and researchers.  Additional Details will be posted as soon as they are available.

Ophthalmology Mock Oral Course is organized by The Osler Institute and will be held from Jun 05 - 07, 2019 at Holiday Inn & Suites Chicago North Shore (Skokie), Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 30 AMA PRA Category 1 Credit(s)™.  Conference Description: Hone your critical reasoning and evaluation skills in an intensive 3-day case review course designed to help you zero in on what is most clinically relevant for diagnosis, treatment approach, and patient management in all essential areas of Ophthalmology. The course begins with a lecture on critical reasoning and communication skills important to passing the Oral Certification exam and that will be emphasized during the mock oral exams to follow. The course covers standard of care relevant cases utilizing a half-hour public mock oral exam with feedback format. Participants and faculty review face-to-face in a 25-minute simulation of the oral board process followed by faculty critique. Course fees include participating in two public mock orals and observing others being examined. Learn by doing and from observing. Participants may purchase additional mock orals if desired (public or private); however, availability may be limited within two weeks of the start of the course. Enter Mock Oral topics preference(s) in the indicated box in the cart during the checkout process. Mock Oral Exam Topics: • Optics, Refraction & Physiology • Neuro-ophthalmology & Orbit • External Eye and Adnexa • Anterior Segment of the Eye • Posterior Segment of the Eye • Pediatrics, and Strabismus Early Bird Special, Save 10% on Registration fee until May 5 Additional details will be posted as soon as they are available.